product iamge

Principles of Anticancer Drug Development

This document was uploaded by one of our users. The uploader already confirmed that they had the permission to publish it. If you are author/publisher or own the copyright of this documents, please report to us by using this DMCA report form.

Download
Search on Amazon

Simply click on the Download Book button.

Yes, Book downloads on Ebookily are 100% Free.

Sometimes the book is free on Amazon As well, so go ahead and hit "Search on Amazon"

A practical guide to the design, conduction, analysis and reporting of clinical trials with anticancer drugs.

Author(s): Elizabeth G. Hill, Elizabeth Garrett-Mayer (auth.), Elizabeth Garrett-Mayer (eds.)
Series: Cancer Drug Discovery and Development
Edition: 1
Publisher: Springer-Verlag New York
Year: 2011

Language: English
Pages: 674
Tags: Cancer Research

Front Matter....Pages i-xvii
Front Matter....Pages 1-1
Basic Biostatistics for the Clinical Trialist....Pages 3-35
Fundamental Concepts in Clinical Pharmacology....Pages 37-62
Bioanalytical Methods in Clinical Drug Development....Pages 63-86
Front Matter....Pages 87-87
Preclinical Models for Anticancer Drug Development....Pages 89-114
Front Matter....Pages 115-115
Phase I Clinical Trials with Anticancer Agents....Pages 117-139
Phase II Trials with Anticancer Agents....Pages 141-161
Phase III Clinical Trials with Anticancer Agents....Pages 163-188
Pharmacokinetic Studies in Early Anticancer Drug Development....Pages 189-214
Pharmacodynamic Studies in Early Phase Drug Development....Pages 215-256
Prediction of Antitumor Response....Pages 257-274
Imaging Studies in Anticancer Drug Development....Pages 275-302
Front Matter....Pages 303-303
Role of the US Food and Drug Administration in Cancer Drug Development....Pages 305-332
Front Matter....Pages 333-333
Early Clinical Trials with Cytotoxic Agents....Pages 335-345
Challenges and Successes in Developing Effective Anti-angiogenic Agents....Pages 347-401
Targeted Therapeutics in Cancer Treatment....Pages 403-461
Cancer Chemoprevention....Pages 463-481
Combined Modality Therapy in Cancer Management....Pages 483-517
Cancer Vaccines....Pages 519-533
Optimising the Development of Antibodies as Treatment for Cancer....Pages 535-567
Oligonucleotide Therapeutics....Pages 569-587
Front Matter....Pages 333-333
Anticancer Drug Development in Pediatric Patients....Pages 589-601
Clinical Trials in Special Populations....Pages 603-628
Front Matter....Pages 629-629
NCI-Sponsored Clinical Trials....Pages 631-657
Back Matter....Pages 659-673